精彩推荐:青光眼 白内障 近视 远视 散光 斜视弱视 角膜溃疡 角膜炎 沙眼 眼外伤 更多疾病
大众频道
专业频道
时尚频道
互动频道
疾 病 | 保 健 | 爱眼动态 | 名医名院
知 识 | 美 食 | 自检自测 | 爱眼纪事
资 讯 | 临 床 | 学 术 | 文 献
图 谱 | 医 患 | 继 教 | 家 园
五官之美 | 整 形 | 美 容
眼镜一族 | 妆 容 | 图 库
眼科在线 | 预留位置
眼科知道 | 在线咨询
  当前位置: 中华眼科在线 >> 医学频道 >> 临床药学 >> 临床研究 切换到繁體中文 用户登录 新用户注册
青光眼药物治疗的回顾和展望

http://www.cnophol.com 2008-1-18 17:25:36 中华眼科在线

11 Chen CS, Wells J, Craig JE.Topical prostaglandin F(2alpha) analog induced poliosis. Am J Ophthalmol ,2004;137:965-966

12 De Santis M, Lucchese A, Carducci B, Cavaliere AF, De Santis L, Merola A, Straface G, Caruso A. Latanoprost Exposure in Pregnancy. Am J Ophthalmol ,2004;138:305-306

13 Drance SM, Nash PA. The dose response of human intraocular pressure to pilocarpine. Can J Ophthalmol ,1971;6:9-13

14 Stamper RL, Wigginton SA, Higginbotham EJ. Primary Drug Treatment for Glaucoma: Beta-Blockers Versus Other Medications. Surv Ophthalmol ,2002;47:63-73

15 Bron AM, Emmerich KH. Latanoprost Versus Combined Timolol and DorzolamideAlain. Surv Ophthalmol ,2002 (Suppl 1 );47:148-154

16 Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F. Dorzolamide/Timolol Combination versus Concomitant Administration of Brimonidine and Timolol Six-Month Comparison of Efficacy and Tolerability. Ophthalmology ,2003;110(3):615-624

17 Toris CB, Alm A, Camras CB.Latanoprost and Cholinergic Agonists in Combination. Surv Ophthalmol ,2002;47(Suppl 1):141-147

18 Day DG, Schacknow PN, Wand M, Sharpe ED, Stewart JA, Leech J, Stewart WC. Timolol 0.5%/Dorzolamide 2% Fixed Combination Vs Timolol Maleate 0.5% and Unoprostone 0.15% Given Twice Daily to Patients With Primary Open-angle Glaucoma or Ocular Hypertension. Am J Ophthalmol ,2003;135(2):138-143

19 Olander K, Zimmerman TJ, Downes N, Schoenfelder J; Xalacom/Latanoprost Study Group. Switching from Latanoprost to Fixed-Combination Latanoprost- Timolol: A 21-Day, Randomized, Double-Masked, Active-Control Study in Patients with Glaucoma and Ocular Hypertension. Clin Ther ,2004;26(10):1619-1629

20 Fechtner RD, Realini T. Fixed combinations of topical glaucoma medications. Curr Opin Ophthalmol ,2004;15(2):132-135

21 Tian B, Wang RF, Podos SM, Kaufman PL..Effects of topical H-7 on outflow facility, intraocular pressure, and corneal thickness in monkeys. Arch Ophthalmol ,2004;122(8):1171-1177

22 Rosenthal R,Choritz L, Schlott S, Bechrakis NE, Jaroszewski J, Wiederholt M, Thieme H Effects of ML-7 and Y-27632 on carbachol- and endothelin-1-induced contraction of bovine trabecular meshwork. Exp Eye Res ,2005;80(6):837-845

23 Zhang M, Rao PV. Blebbistatin,a Novel Inhibitor of Myosin II ATPase Activity, Increases Aqueous Humor Outflow Facility in Perfused Enucleated Porcine Eyes. Invest Ophthalmol Vis Sci ,2005;46(11):4130-4138

24 Song J, Deng PF, Stinnett SS, Epstein DL, Rao PV. Effects of Cholesterol-Lowering Statins on the Aqueous Humor Outflow Pathway. Invest Ophthalmol Vis Sci,2005;46(7):2424-2432

25 Gabelt BT, Hu Y, Vittitow JL, Rasmussen CR, Grosheva I, Bershadsky AD, Geiger B, Borras T, Kaufman PL. Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res ,2006;82(6):935-944

26 Mettu PS, Deng PF, Misra UK, Gawdi G, Epstein DL, Rao PV. Role of Lysophospholipid Growth Factors in the Modulation of Aqueous Humor Outflow Facility. Invest Ophthalmol Vis Sci ,2004;45(7):2263-2271

27 Rauz S, Cheung CM, Wood PJ, Coca-Prados M, Walker EA, Murray PI, Stewart PM.Inhibition of 11b-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension. QJM ,2003;96(7):481-490

28 Sharif NA, Kelly CR, McLaughlin M. Human Trabecular Meshwork Cells Express Functional Serotonin-2A (5HT2A) Receptors: Role in IOP Reduction. Invest Ophthalmol Vis Sci ,2006;47(9):4001-4010

29 May JA, Dantanarayana AP, Zinke PW, McLaughlin MA, Sharif NA. 1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity. J Med Chem ,2006;49(1):318-328

30 Zhan GL, Camras CB, Palmberg PF, Toris CB Effects of Marijuana on Aqueous Humor Dynamics in a Glaucoma Patient. J Glaucoma ,2005;14(2):175-177

31 Tomida I, Pertwee RG, Azuara-Blanco A. Cannabinoids and glaucoma. Br J Ophthalmol ,2004;88(5):708-713

32 Zhang X, Krishnamoorthy RR, Prasanna G, Narayan S, Clark A, Yorio T. Dexamethasone regulates endothelin-1 and endothelin receptors in human non- pigmentedciliaryepithelial(HNPE)cells. Exp Eye Res ,2003;76(3):261-272

33 Prasanna G, Hulet C, Desai D, Krishnamoorthy RR, Narayan S, Brun AM, Suburo AM, Yorio T. Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma. Pharmacol Res ,2005;51(1):41-50

34 Pintor J. Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma. Curr Opin Investig Drugs ,2005;6(1):76-80

35 Soto D, Pintor J, Peral A, Gual A, Gasull X. Effects of dinucleoside polyphosphates on trabecular meshwork cells and aqueous humor outflow facility. J Pharmacol Exp Ther ,2005;314(3):1042-1051

36 Konno T. Role of adenosine in intraocular pressure .Nippon Yakurigaku Zasshi ,2004;123 (4):289-294

37 Shah GB, Sharma S, Mehta AA, Goyal RK. Oculohypotensive Effect of Angiotensin- Converting Enzyme Inhibitors in Acute and Chronic Models of Glaucoma. J Cardiovasc Pharmacol ,2000;36(2):169-175

38 Naveh N, Kaplan-Messas A, Marshall J. Mechanism related to reduction of intraocular pressure by melanocortins in rabbits. Br J Ophthalmol ,2000;84(12):1411-1414

39 Serle JB, Wang RF, Peterson WM, Plourde R, Yerxa BR. Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes. J Glaucoma ,2004;13(5):385-388

40 Li ZY, Chang JH, Milam AH. A gradient of basic fibroblast growth factor in rod photoreceptors in the normal human retina. Vis Neurosci ,1997;14(4):671-679

41 Richardson PM. Ciliary neurotrophic factor: a review. Pharmacol Ther. Pharmacol Ther ,1994;63(2):187-198

42 Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Nat Acad Sci USA ,1994;91(5):1632-1636

43 Burren CP, Berka JL, Edmondson SR, Werther GA, Batch JA. Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye. Invest Ophthalmol Vis Sci ,1996;37(7):1459-1468

44 Neufeld AH. Nitric Oxide: A Potential Mediator of Retinal Ganglion Cell Damage in Glaucoma. Surv Ophthalmol ,1999;43(Suppl 1 ):129-135

45 Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci ,1990;10(3):1035-1041

46 Neacsu A, Oprean C, Curea M, Tuchila G, Trifu M. Neuroprotection with carotenoids in glaucoma. Ophthalmologia ,2003;59 (4):70-75

47 Reed JC. Apoptosis-based therapies. Nat Rev Drug Discov ,2002;1:111-121

48 Thiagarajan G, Chandani S, Harinarayana Rao S, Samuni AM, Chandrasekaran K, Balasubramanian D . Molecular and cellular assessment of Ginkgo Biloba Extract as a possible ophthalmic drug. Exp Eye Res ,2002;75(4):421-430

49 Tsai JC, Wu L, Worgul B, Forbes M, Cao J. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat.model of glaucoma. Curr Eye Res. ,2005;30(11):1025-1031

50 Zheng H, Youdim MB, Weiner LM, Fridkin M. Novel potential neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons. Biochem Pharmacol ,2005;70(11):1642-1652

51 Garhofer G, Resch H, Lung S, Weigert G, Schmetterer L. Intravenous Administration of L-Arginine Increases Retinal and Choroidal Blood Flow. Am J Ophthalmol ,2005;140(1):69-76

52 Koksal M, Ozdemir H, Kargi S, Yesilli C, Tomac S, Mahmutyazicioglu K, Mungan A. The effects of sildenafil on ocular blood flow. Acta Ophthalmol Scand ,2005;83(3):355-359

53 Zou YH, Chiou GGY. New idens for medical therapy of glaucoma in the fature. Int J Ophthalmol (Guoji Yanke Zazhi) ,2005;5(3):411-422

54 van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH. Intraocular Pressure-Lowering Effects of All Commonly Used Glaucoma Drugs A Meta-analysis of Randomized Clinical Trials. Ophthalmology ,2005;112(7):1177-1185

上一页  [1] [2] [3] [4] [5] [6] [7] 

(来源:中华现代眼耳鼻喉科杂志)(责编:xhhdm)

下一条:
更多关于(眼科,眼睛,眼科疾病,眼科用药,眼科临床,药物研究,青光眼)的信息
  热门图文

眼袋日常护肤8大高招

5款至酷太阳镜 型男必

08韩国时尚达人眼镜秀

炫酷太阳镜打造时尚酷
  健康新看点
  健康多视点
  图话健康

Copyright © 2007 中华眼科在线 网站备案序列号: 京ICP备06023366号
本网站由五景药业主办 北京金鼎盛世医学传媒机构负责运营 国家医学教育发展中心提供学术支持
服务电话:010-63330565 服务邮箱: [email protected]